Pharmac unmoved on Ventolin subsidy

Drug-funding agency Pharmac will not review its decision to drop the subsidy for its popular asthma inhaler Ventolin, saying a study that found its Salamol replacement (which Pharmac now subsidises) to be less effective had "many, many faults".